KHN analysis: The revolving door between Capitol Hill and the drug industry
KHN analysis showed that more than a dozen former drug industry employees now have jobs on Capitol Hill — often on committees that handle health care policy.
KHN analysis showed that more than a dozen former drug industry employees now have jobs on Capitol Hill — often on committees that handle health care policy.
Behind-the-scenes partnerships between the pharmaceutical industry and advocacy groups may work against lowering the cost of high-priced drugs.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.